Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05739851

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

Conditions: Healthy

Sex: All
Ages: 19 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 40
Sponsor: Dong-A ST Co., Ltd.

Location: Korea, Republic of

Summary

This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01(2.5/500 mg) at fasting state.

Eligibility Criteria

Inclusion Criteria:Healthy VolunteersBMI between 18 and 30 kg/m2Body weight : Male≥50kg, Female≥45kgExclusion Criteria:Allergy or Drug hypersensitivityClinically significant Medical History

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05739851). StuddyBuddy aggregates publicly available trial information.